These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 4524857)

  • 1. Leukemia and the hypercoagulable state. Pathogenic and therapeutic implications.
    Brodsky I
    J Med; 1974; 5(1):38-49. PubMed ID: 4524857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glycosaminoglycans of human thrombocytes in normal conditions, in chronic myeloid leukosis, myelofibrosis and polycythemia vera].
    Kharchenko MF
    Vopr Med Khim; 1973; 19(6):613-7. PubMed ID: 4277844
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I; Kahn SB; Ross EM; Petkov G
    Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y
    Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
    [No Abstract]   [Full Text] [Related]  

  • 5. [The therapy of hemoblastosis and malignant lymphoma. I. Leukosis, polycythemia vera and osteomyelosclerosis].
    Löffler H; Schultis K
    Med Welt; 1968 Jan; 1():96-100. PubMed ID: 5704123
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet defects in the myeloproliferative disorders.
    Inceman S; Tangün Y
    Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role and participation of thrombocytes in hemostasis in the myeloproliferative syndrome].
    Zaĭtseva VN
    Vrach Delo; 1971 Jan; (1):72-6. PubMed ID: 5280699
    [No Abstract]   [Full Text] [Related]  

  • 8. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
    Barbui T; Battista R; Dini E
    Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].
    Petrov MN; Vashkinel' VK
    Probl Gematol Pereliv Krovi; 1977 May; 22(5):18-23. PubMed ID: 267283
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the effect of a new cytostatic drug in chronic myeloses and polycythemias].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1968 Sep; 118(37):721-3. PubMed ID: 5248360
    [No Abstract]   [Full Text] [Related]  

  • 11. Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
    Zetterqvist E
    Acta Physiol Scand Suppl; 1969; 325():1-41. PubMed ID: 4900570
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin treatment of intravascular coagulation accompanying hemolytic transfusion reactions.
    Rock RC; Bove JR; Nemerson Y
    Anesth Analg; 1970; 49(2):231-5. PubMed ID: 4996107
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinogen. Heparin. Panic.
    Houts RE
    Trans Pac Coast Obstet Gynecol Soc; 1970; 37():55-60. PubMed ID: 5315019
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemostasis disorders with reduced activity of the von Willebrand factor in myeloproliferative syndromes].
    Leupin L; Beck EA; Furlan M; Bucher U
    Schweiz Med Wochenschr; 1983 May; 113(19):713-6. PubMed ID: 6603016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early heparin therapy in 60 children with acute meningococcemia. Relationship between clinical manifestations and coagulation abnormalities.
    Blum D; Fondu P; Denolin-Reubens R; Dubois J
    Acta Chir Belg; 1973 Jul; 72(4):288-97. PubMed ID: 4766888
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of myeloproliferative diseases.
    Sellei C
    Ther Hung; 1966; 14(4):135-6. PubMed ID: 5228101
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of AGL.
    Lee SL; Rosner F
    Arch Intern Med; 1969 Feb; 123(2):205-6. PubMed ID: 5249563
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute promyelocytic leukemia.
    Armitage JO; Davis RB; Rigby PG
    Rocky Mt Med J; 1975 Aug; 72(8):334-9. PubMed ID: 1058512
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of abnormal LDH isoenzyme pattern in human platelets.
    Knudsen FU
    Acta Haematol; 1971; 45(2):99-105. PubMed ID: 4996571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.